Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Exp Dermatol ; 24(3): 198-203, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25431356

RESUMEN

Skin wound healing is a complex process involving many types of cells and molecules and often results in scar tissue formation in adult mammals. However, scarless healing occurs in foetal skin and minimal scars may occur after cutaneous healing in the adult with reduced inflammation. Alpha-melanocyte-stimulating hormone (α-MSH) is widely distributed within the central nervous system and in other body regions, such as the skin, and has strong anti-inflammatory activity. The aim in the present experiments was to learn whether intraperitoneal (i.p) injection of α-MSH just before skin wounds antagonize inflammation and improves skin wound healing in adult mice. C57BL/6 young adult mice received an i.p. injection of 1 mg/kg of α-MSH and, 30 min later, two circular through-and-through holes (6.5 mm diameter) were made in their dorsal skin under anaesthesia. Control mice were wounded after vehicle injection. The wound healing process was analysed macroscopically and microscopically at 3, 7, 40 and 60 days. Skin samples were fixed in formalin, embedded in paraffin, sectioned at 5 µm, stained with H&E or toluidine blue for cell analysis or Gomori's trichrome for extracellular matrix (ECM) analysis. Other samples were fixed in DMSO+methanol, embedded in paraplast and incubated with anti-CD45, antismooth muscle actin, anticollagen-I and anticollagen-III for immunofluorescence analysis. Alpha-MSH significantly reduced the number of leucocytes, mast cells and fibroblasts at 3 and 7 days after injury. On days 40 and 60, α-MSH reduced scar area and improved the organization of the collagen fibres indicating that it may direct the healing into a more-regenerative/less-scarring pathway.


Asunto(s)
Hormonas/farmacología , Piel/citología , Cicatrización de Heridas/efectos de los fármacos , alfa-MSH/farmacología , Animales , Cicatriz/prevención & control , Colágeno/efectos de los fármacos , Colágeno/metabolismo , Colágeno/ultraestructura , Fibroblastos/efectos de los fármacos , Inflamación/prevención & control , Inyecciones Intraperitoneales , Recuento de Leucocitos , Masculino , Mastocitos/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Piel/efectos de los fármacos , Fenómenos Fisiológicos de la Piel/efectos de los fármacos
2.
BMC Res Notes ; 6: 174, 2013 May 02.
Artículo en Inglés | MEDLINE | ID: mdl-23639061

RESUMEN

BACKGROUND: Low-stringency single specific primer PCR (LSSP-PCR) is a highly sensitive and discriminating technique that has been extensively used to genetically characterize Trypanosoma cruzi populations in the presence of large amounts of host DNA. To ensure high sensitivity, in most T. cruzi studies, the variable regions of the naturally amplified kinetoplast DNA (kDNA) minicircles were targeted, and this method translated the intraspecific polymorphisms of these molecules into specific and reproducible kDNA signatures. Although the LSSP-PCR technique is reproducible under strict assay conditions, the complex banding pattern generated can be significantly altered by even a single-base change in the target DNA. Our survey of the literature identified eight different primers with similar, if not identical, names that have been used for kDNA amplification and LSSP-PCR of T. cruzi. Although different primer sequences were used in these studies, many of the authors cited the same reference report to justify their primer choice. We wondered whether these changes in the primer sequence could affect also the parasite LSSP-PCR profiles. FINDINGS: To answer this question we compared the kDNA signatures obtained from three different and extensively studied T. cruzi populations with the eight primers found in the literature. Our results clearly demonstrate that even minimal modifications in the oligonucleotide sequences, especially in the 3' or 5' end, can significantly change the kDNA signature of a T. cruzi strain. CONCLUSIONS: These results highlight the necessity of careful preservation of primer nomenclature and sequence when reproducing an LSSP-PCR work to avoid confusion and allow comparison of results among different laboratories.


Asunto(s)
ADN de Cinetoplasto/genética , Reacción en Cadena de la Polimerasa/métodos , Trypanosoma cruzi/genética , Animales , Secuencia de Bases , Cartilla de ADN
3.
Clin Dev Immunol ; 2012: 293625, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22013486

RESUMEN

Parenteral injection of tolerated proteins into orally tolerant mice inhibits the initiation of immunological responses to unrelated proteins and blocks severe chronic inflammatory reactions of immunological origin, such as autoimmune reactions. This inhibitory effect which we have called "indirect effects of oral tolerance" is also known as "bystander suppression." Herein, we show that i.p. injection of OVA + Al(OH)(3) minutes before i.v. injection of Schistosoma mansoni eggs into OVA tolerant mice blocked the increase of pulmonary granulomas. In addition, the expression of ICAM-1 in lung parenchyma in areas outside the granulomas of OVA-orally tolerant mice was significantly reduced. However, at day 18 after granuloma induction there was no difference in immunofluorescency intensity to CD3, CD4, F4/80, andα-SMA per granuloma area of tolerant and control groups. Reduction of granulomas by reexposure to orally tolerated proteins was not correlated with a shift in Th-1/Th-2 cytokines in serum or lung tissue extract.


Asunto(s)
Efecto Espectador , Granuloma/inmunología , Pulmón/metabolismo , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/inmunología , Administración Oral , Animales , Antígenos CD/metabolismo , Células Cultivadas , Huevos/parasitología , Granuloma/etiología , Granuloma/patología , Granuloma/fisiopatología , Tolerancia Inmunológica , Inmunofenotipificación , Inflamación , Molécula 1 de Adhesión Intercelular/genética , Molécula 1 de Adhesión Intercelular/metabolismo , Pulmón/inmunología , Pulmón/parasitología , Pulmón/patología , Ratones , Ratones Endogámicos C57BL , Ovalbúmina/administración & dosificación , Schistosoma mansoni/patogenicidad , Esquistosomiasis mansoni/complicaciones , Esquistosomiasis mansoni/patología , Esquistosomiasis mansoni/fisiopatología
4.
PLoS Negl Trop Dis ; 4(10): e846, 2010 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-20967289

RESUMEN

A century after the discovery of Trypanosoma cruzi in a child living in Lassance, Minas Gerais, Brazil in 1909, many uncertainties remain with respect to factors determining the pathogenesis of Chagas disease (CD). Herein, we simultaneously investigate the contribution of both host and parasite factors during acute phase of infection in BALB/c mice infected with the JG and/or CL Brener T. cruzi strains. JG single infected mice presented reduced parasitemia and heart parasitism, no mortality, levels of pro-inflammatory mediators (TNF-α, CCL2, IL-6 and IFN-γ) similar to those found among naïve animals and no clinical manifestations of disease. On the other hand, CL Brener single infected mice presented higher parasitemia and heart parasitism, as well as an increased systemic release of pro-inflammatory mediators and higher mortality probably due to a toxic shock-like systemic inflammatory response. Interestingly, coinfection with JG and CL Brener strains resulted in intermediate parasitemia, heart parasitism and mortality. This was accompanied by an increase in the systemic release of IL-10 with a parallel increase in the number of MAC-3(+) and CD4(+) T spleen cells expressing IL-10. Therefore, the endogenous production of IL-10 elicited by coinfection seems to be crucial to counterregulate the potentially lethal effects triggered by systemic release of pro-inflammatory mediators induced by CL Brener single infection. In conclusion, our results suggest that the composition of the infecting parasite population plays a role in the host response to T. cruzi in determining the severity of the disease in experimentally infected BALB/c mice. The combination of JG and CL Brener was able to trigger both protective inflammatory immunity and regulatory immune mechanisms that attenuate damage caused by inflammation and disease severity in BALB/c mice.


Asunto(s)
Enfermedad de Chagas/inmunología , Trypanosoma cruzi/inmunología , Trypanosoma cruzi/patogenicidad , Animales , Linfocitos T CD4-Positivos/inmunología , Enfermedad de Chagas/mortalidad , Enfermedad de Chagas/patología , Citocinas/sangre , Modelos Animales de Enfermedad , Masculino , Ratones , Ratones Endogámicos BALB C , Miocardio/patología , Parasitemia , Análisis de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA